Molecular dynamics study of non-nucleoside reverse transcriptase inhibitor 4-[[4-[[4-[(E)-2-cyanoethenyl]-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile (TMC278/rilpivirine) aggregates: correlation between amphiphilic properties of the drug and oral bioavailability.

The non-nucleoside reverse transcriptase inhibitor (NNRTI) TMC278/rilpivirine is an anti-AIDS therapeutic agent with high oral bioavailability despite its high hydrophobicity. Previous studies established a correlation between ability of the drug molecule to form stable, homogeneous populations of spherical nanoparticles (approximately 100-120 nm in diameter) at low pH in surfactant-independent fashion and good oral bioavailability. Here, we hypothesize that the drug is able to assume surfactant-like properties under physiologically relevant conditions, thus facilitating formation of nanostructures in the absence of other surfactants. The results of all-atom molecular dynamics simulations indeed show that protonated drug molecules behave as surfactants at the water/aggregate interface while neutral drug molecules assist aggregate packing via conformational variability. Our simulation results suggest that amphiphilic behavior at low pH and intrinsic flexibility influence drug aggregation and are believed to play critical roles in the favorable oral bioavailability of hydrophobic drugs.

[1]  M. J. Rosen.  Surfactants and Interfacial Phenomena , 1978 .

[2]  P. G. de Gennes,et al.  Microemulsions and the flexibility of oil/water interfaces , 1982 .

[3]  G. D. Parfitt,et al.  Interfacial Phenomena in Apolar Media , 1986 .

[4]  K. Sharp,et al.  Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons , 1991, Proteins.

[5]  Li-Jen Chen.  Area dependence of the surface tension of a Lennard‐Jones fluid from molecular dynamics simulations , 1995 .

[6]  W. L. Jorgensen,et al.  Development and Testing of the OPLS All-Atom Force Field on Conformational Energetics and Properties of Organic Liquids , 1996 .

[7]  N. Maurits,et al.  The dynamic mean-field density functional method and its application to the mesoscopic dynamics of quenched block copolymer melts , 1997 .

[8]  Kaoru Tsujii,et al.  Surface Activity: Principles, Phenomena and Applications , 1998 .

[9]  A. Serajuddin,et al.  Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. , 1999, Journal of pharmaceutical sciences.

[10]  O. Regev,et al.  Aggregation Behavior of Tyloxapol, a Nonionic Surfactant Oligomer, in Aqueous Solution. , 1999, Journal of colloid and interface science.

[11]  Z. A. Schelly,et al.  Atomic-Level Molecular Modeling of AOT Reverse Micelles. 1. The AOT Molecule in Water and Carbon Tetrachloride , 1999 .

[12]  Harry A. Stern,et al.  Fluctuating Charge, Polarizable Dipole, and Combined Models: Parameterization from ab Initio Quantum Chemistry , 1999 .

[13]  Ruhong Zhou,et al.  Parametrizing a polarizable force field from ab initio data. I. The fluctuating point charge model , 1999 .

[14]  C. Pouton,et al.  Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[15]  S. Benita,et al.  Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[16]  R. Pauwels,et al.  Evolution of anti-HIV drug candidates. Part 1: From alpha-anilinophenylacetamide (alpha-APA) to imidoyl thiourea (ITU). , 2001, Bioorganic & medicinal chemistry letters.

[17]  B. Berne,et al.  Combined fluctuating charge and polarizable dipole models: Application to a five-site water potential function , 2001 .

[18]  R. Pauwels,et al.  Evolution of anti-HIV drug candidates. Part 1: From α-Anilinophenylacetamide (α-APA) to imidoyl thiourea (ITU) , 2001 .

[19]  R. Pauwels,et al.  Evolution of anti-HIV drug candidates. Part 3: Diarylpyrimidine (DAPY) analogues. , 2001, Bioorganic & medicinal chemistry letters.

[20]  Harry A. Stern,et al.  Development of a polarizable force field for proteins via ab initio quantum chemistry: First generation model and gas phase tests , 2002, J. Comput. Chem..

[21]  B. Shoichet,et al.  A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening. , 2002, Journal of medicinal chemistry.

[22]  Hubert Kuhn,et al.  Molecular dynamic computer simulations of phase behavior of non-ionic surfactants. , 2002, Angewandte Chemie.

[23]  B. Shoichet,et al.  A specific mechanism of nonspecific inhibition. , 2003, Journal of medicinal chemistry.

[24]  B. Shoichet,et al.  Identification and prediction of promiscuous aggregating inhibitors among known drugs. , 2003, Journal of medicinal chemistry.

[25]  Eddy Arnold,et al.  On the detection of multiple-binding modes of ligands to proteins, from biological, structural, and modeling data , 2003, J. Comput. Aided Mol. Des..

[26]  J E Kipp,et al.  The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs. , 2004, International journal of pharmaceutics.

[27]  Brian K. Shoichet,et al.  Virtual screening of chemical libraries , 2004, Nature.

[28]  H. M. Vinkers,et al.  Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants. , 2004, Journal of medicinal chemistry.

[29]  J. Crison,et al.  A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability , 1995, Pharmaceutical Research.

[30]  S. Bhattacharya,et al.  Thermodynamics of micellization of multiheaded single-chain cationic surfactants. , 2004, Langmuir : the ACS journal of surfaces and colloids.

[31]  A. D. Clark,et al.  Correlations between Factors Determining the Pharmacokinetics and Antiviral Activity of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors of the Diaryltriazine and Diarylpyrimidine Classes of Compounds , 2004, Drugs in R&D.

[32]  S. Benita,et al.  Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. , 2004, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[33]  George A. Kaminski,et al.  Development of an Accurate and Robust Polarizable Molecular Mechanics Force Field from ab Initio Quantum Chemistry , 2004 .

[34]  Paul J Lewi,et al.  Concentration and pH dependent aggregation of hydrophobic drug molecules and relevance to oral bioavailability. , 2005, Journal of medicinal chemistry.

[35]  V. Aswal,et al.  Unusual micellar properties of multiheaded cationic surfactants in the presence of strong charge neutralizing salts. , 2005, Journal of colloid and interface science.

[36]  B. Shoichet,et al.  High-throughput assays for promiscuous inhibitors , 2005, Nature chemical biology.

[37]  Stephen H Hughes,et al.  Crystallography and the design of anti-AIDS drugs: conformational flexibility and positional adaptability are important in the design of non-nucleoside HIV-1 reverse transcriptase inhibitors. , 2005, Progress in biophysics and molecular biology.

[38]  Stephen H Hughes,et al.  In search of a novel anti-HIV drug: multidisciplinary coordination in the discovery of 4-[[4-[[4-[(1E)-2-cyanoethenyl]-2,6-dimethylphenyl]amino]-2- pyrimidinyl]amino]benzonitrile (R278474, rilpivirine). , 2005, Journal of medicinal chemistry.

[39]  Richard A. Friesner,et al.  Integrated Modeling Program, Applied Chemical Theory (IMPACT) , 2005, J. Comput. Chem..

[40]  Yixiang Cao,et al.  A Polarizable Force Field and Continuum Solvation Methodology for Modeling of Protein-Ligand Interactions. , 2005, Journal of chemical theory and computation.

[41]  B. Shoichet.  Screening in a spirit haunted world. , 2006, Drug discovery today.

[42]  Colin W Pouton,et al.  Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[43]  Brian K Shoichet,et al.  A detergent-based assay for the detection of promiscuous inhibitors , 2006, Nature Protocols.

[44]  Hongyan Wang,et al.  Dissipative particle dynamics simulation of the phase behavior and microstructure of CTAB/octane/1-butanol/water microemulsion , 2007 .

[45]  리벤 엘비레 콜레테 바에르트,et al.  Process for preparing spray dried formulations of tmc125 , 2007 .

[46]  S. Stegemann,et al.  When poor solubility becomes an issue: from early stage to proof of concept. , 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[47]  Abu T M Serajuddin,et al.  Salt formation to improve drug solubility. , 2007, Advanced drug delivery reviews.

[48]  A. Narang,et al.  Stable drug encapsulation in micelles and microemulsions. , 2007, International journal of pharmaceutics.

[49]  S. Thayumanavan,et al.  Smaller building blocks form larger assemblies: aggregation behavior of biaryl-based dendritic facial amphiphiles. , 2007, The Journal of organic chemistry.

[50]  B. Griffin,et al.  Biopharmaceutical challenges associated with drugs with low aqueous solubility--the potential impact of lipid-based formulations. , 2008, Advanced drug delivery reviews.

[51]  C. Pouton,et al.  Enhancing intestinal drug solubilisation using lipid-based delivery systems. , 2008, Advanced drug delivery reviews.

[52]  Stephen H Hughes,et al.  High-resolution structures of HIV-1 reverse transcriptase/TMC278 complexes: Strategic flexibility explains potency against resistance mutations , 2008, Proceedings of the National Academy of Sciences.

[53]  A. Tikhonov,et al.  Molecular ordering and phase behavior of surfactants at water-oil interfaces as probed by X-ray surface scattering. , 2008, Annual review of physical chemistry.

[54]  Kristin E. D. Coan,et al.  Stoichiometry and physical chemistry of promiscuous aggregate-based inhibitors. , 2008, Journal of the American Chemical Society.

[55]  Tycho Heimbach,et al.  Prodrugs: design and clinical applications , 2008, Nature Reviews Drug Discovery.